close

Agreements

Date: 2018-09-17

Type of information: Collaboration agreement

Compound: cloud-based informatics research platform

Company: Accenture (Ireland) Amazon (USA - CA) Merck&Co (USA - NJ)

Therapeutic area: Technology - Services

Type agreement: collaboration

Action mechanism:

Disease:

Details:

  • • On September 17, 2018, Accenture and Merck&Co, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development.
  • The new research platform, being developed by Merck&Co and Accenture, will enable an ecosystem that accelerates innovation by creating open, industry-standard application programming interfaces for core research functions, allowing researchers to rapidly adopt new capabilities. Scientific application providers, content providers and technology innovators will benefit from lower barriers to entry as they bring new capabilities to market, helping life sciences companies re-imagine processes, user experiences, and approaches to data-intensive research.
  • The platform will allow life sciences researchers and informatics professionals to quickly aggregate, access and analyze research data from multiple applications. Data will now be accessible through a single set of interfaces, with integrated workflow, reporting and analytics capabilities. Incorporating a modern user interface and a secure, multi-tenant environment, the platform will unify user experience elements and enable easier collaboration across the research and development (R&D) enterprise, including with external partners.e the discovery of new, targeted treatments for patients.
  • Merck&Co is collaborating with Accenture on this launch and will be the first pharmaceutical company to use the platform.
  • The platform is built on AWS, leveraging its secure cloud services to help increase operational efficiency, strengthen business intelligence, and quickly develop innovative products and services. This is one of the outcomes of the ongoing collaboration between Accenture and AWS through the Accenture AWS Business Group.
  • Accenture is also forming a coalition of clients to govern and further advance the capabilities of this platform, offering an opportunity for pre-competitive industry collaboration. The platform is available to pharmaceutical, biotech and scientific research organizations that are seeking unique approaches to solve research informatics challenges.

Financial terms:

Latest news:

Is general: Yes